Received: 30 July 2020
Accepted: 22 November 2020
First Online: 22 December 2020
Ethics approval and consent to participate
: Not applicable (NA)
: M.H. Cnossen has received investigator-initiated research and travel grants over the years from the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Dutch ‘Innovatiefonds Zorgverzekeraars’, Pfizer, Baxter/Baxalta/Shire, Bayer Schering Pharma, CSL Behring, Sobi, Novo Nordisk, Novartis and Nordic Pharma and has served as a steering board member for Roche and Bayer. All grants, awards and fees go to the institution. P.J. de Pagter has received a grant from Rotary Foundation for the institution. All other authors declare no conflicts of interest relevant to the contents of this manuscript.